Compare PRAX & OSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | OSK |
|---|---|---|
| Founded | 2015 | 1917 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 11.0B |
| IPO Year | 2020 | 2009 |
| Metric | PRAX | OSK |
|---|---|---|
| Price | $325.47 | $166.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 14 |
| Target Price | ★ $572.13 | $163.21 |
| AVG Volume (30 Days) | 364.5K | ★ 822.3K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.36% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | N/A | ★ $7,705,500,000.00 |
| Revenue This Year | N/A | $6.12 |
| Revenue Next Year | $6,395.88 | $6.54 |
| P/E Ratio | ★ N/A | $147.52 |
| Revenue Growth | N/A | ★ 12.83 |
| 52 Week Low | $26.70 | $76.82 |
| 52 Week High | $354.87 | $180.49 |
| Indicator | PRAX | OSK |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 52.44 |
| Support Level | $290.36 | $123.32 |
| Resistance Level | N/A | $180.25 |
| Average True Range (ATR) | 18.34 | 6.22 |
| MACD | -2.56 | -1.60 |
| Stochastic Oscillator | 57.24 | 30.78 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.